Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Cursons

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Nucleic Acids Research|August 3, 2019
Extensive transcriptional responses are co-ordinated by microRNAs as revealed by Exon-Intron Split Analysis (EISA)Katherine A Pillman, Kaitlin G Scheer, Emily Hackett-Jones, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 22, 2023
Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast CancerCharlene Waryah, Joseph Cursons, Momeneh Foroutan, et al.
Cancer Cell|June 13, 2025
Enhancing anti-tumor immunity of natural killer cells through targeting IL-15R signalingIva Nikolic, Joseph Cursons, Benjamin Shields, et al.
Science Signaling|August 29, 2019
Therapeutic blockade of activin-A improves NK cell function and antitumor immunityJai Rautela, Laura F Dagley, Carolina C de Oliveira, et al.
Nature Communications|March 27, 2021
The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancerEmily Golden, Rabab Rashwan, Eleanor A Woodward, et al.
IEEE Transactions on Bio-Medical Engineering|June 16, 2016
Toward Community Standards and Software for Whole-Cell ModelingDagmar Waltemath, Jonathan R Karr, Frank T Bergmann, et al.
Cell Chemical Biology|August 9, 2023
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancerShikhar Sharma, Chi-Yeh Chung, Sean Uryu, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Nucleic Acids Research|August 3, 2019
Extensive transcriptional responses are co-ordinated by microRNAs as revealed by Exon-Intron Split Analysis (EISA)Katherine A Pillman, Kaitlin G Scheer, Emily Hackett-Jones, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 22, 2023
Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast CancerCharlene Waryah, Joseph Cursons, Momeneh Foroutan, et al.
Cancer Cell|June 13, 2025
Enhancing anti-tumor immunity of natural killer cells through targeting IL-15R signalingIva Nikolic, Joseph Cursons, Benjamin Shields, et al.
Science Signaling|August 29, 2019
Therapeutic blockade of activin-A improves NK cell function and antitumor immunityJai Rautela, Laura F Dagley, Carolina C de Oliveira, et al.
Nature Communications|March 27, 2021
The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancerEmily Golden, Rabab Rashwan, Eleanor A Woodward, et al.
IEEE Transactions on Bio-Medical Engineering|June 16, 2016
Toward Community Standards and Software for Whole-Cell ModelingDagmar Waltemath, Jonathan R Karr, Frank T Bergmann, et al.
Cell Chemical Biology|August 9, 2023
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancerShikhar Sharma, Chi-Yeh Chung, Sean Uryu, et al.
Pageof 4